These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6424183)

  • 21. Nonhemolytic hyperbilirubinemias.
    Hollander IJ
    Ann Clin Lab Sci; 1980; 10(3):204-8. PubMed ID: 6994579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).
    Strassburg CP
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):555-71. PubMed ID: 20955959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited disorders of bilirubin clearance.
    Memon N; Weinberger BI; Hegyi T; Aleksunes LM
    Pediatr Res; 2016 Mar; 79(3):378-86. PubMed ID: 26595536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilirubin metabolism. Review and discussion of inborn errors.
    Valaes T
    Clin Perinatol; 1976 Mar; 3(1):177-209. PubMed ID: 821690
    [No Abstract]   [Full Text] [Related]  

  • 25. [Crigler-Najjar syndrome].
    Torres M; Bruguera M
    Gastroenterol Hepatol; 2005 Dec; 28(10):637-40. PubMed ID: 16373016
    [No Abstract]   [Full Text] [Related]  

  • 26. Hereditary disorders of bilirubin metabolism.
    Gollan JL; Billing BH
    Acta Hepatogastroenterol (Stuttg); 1974 Oct; 21(5):333-8. PubMed ID: 4217536
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of bilirubin UDP-glucuronosyltransferase gene mutations in an unusual Crigler-Najjar syndrome patient.
    Liu WL; Li F; He ZX; Jiang HY; Ai R; Chen XX; Huang K
    Mol Med Rep; 2012 Sep; 6(3):667-9. PubMed ID: 22710376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenobarbital therapy in congenital nonhemolytic hyperbilirubinemia (Crigler-Najjar)--report of 5 cases].
    Schellong G; Soennecken U
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):422-4. PubMed ID: 5093938
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.
    Kummer O; Hammann F; Haschke M; Krähenbühl S
    Br J Clin Pharmacol; 2016 May; 81(5):1002-4. PubMed ID: 26692114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Binding of bilirubin to serum albumin in Crigler-Najjar syndrome, type I].
    Ihara H; Aoki Y; Aoki T; Toyoda M
    Rinsho Byori; 1986 Sep; 34(9):1075-8. PubMed ID: 3795542
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inherited disorders of bilirubin metabolism].
    Rossi F; Francese M; Iodice RM; Falcone E; Vetrella S; Punzo F; De Vita S; Perrotta S
    Minerva Pediatr; 2005 Apr; 57(2):53-63. PubMed ID: 15985997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful photo-and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II.
    Holstein A; Plaschke A; Lohse P; Egberts EH
    Scand J Gastroenterol; 2005 Sep; 40(9):1124-6. PubMed ID: 16211719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Crigler-Najjar's congenital familial non-hemolytic jaundice with kernicterus].
    Plöchl E; Hohenwallner W
    Wien Med Wochenschr; 1978 Feb; 128(3):70-3. PubMed ID: 75612
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.
    Trotman BW; Shaw L; Roy-Chowdhury J; Malet PF; Rosato EF
    Dig Dis Sci; 1983 Aug; 28(8):753-62. PubMed ID: 6872808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Crigler-Najjar syndrome. Quantitation of ultrastructural data and evolution under therapy with phenytoin.
    Koch MM; Lorenzini I; Freddara U; Jezequel AM; Orlandi F
    Gastroenterol Clin Biol; 1978 Oct; 2(10):831-42. PubMed ID: 729981
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute hepatitis in Crigler-Najjar syndrome.
    Sherker AH; Heathcote J
    Am J Gastroenterol; 1987 Sep; 82(9):883-5. PubMed ID: 3115090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and significance of fasting and dietary hyperbilirubinemia.
    Whitmer DI; Gollan JL
    Semin Liver Dis; 1983 Feb; 3(1):42-51. PubMed ID: 6340207
    [No Abstract]   [Full Text] [Related]  

  • 38. Bilirubin metabolism and congenital jaundice.
    Gollan JL; Knapp AB
    Hosp Pract (Off Ed); 1985 Feb; 20(2):83-7, 90, 92-3 passim. PubMed ID: 3918071
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II.
    Gordon ER; Shaffer EA; Sass-Kortsak A
    Gastroenterology; 1976 May; 70(5 PT.1):761-5. PubMed ID: 1261771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistant unconjugated hyperbilirubinemia in an infant with crigler-najjar syndrome type I.
    Kulkarni ML; C NR
    Indian Pediatr; 2003 Dec; 40(12):1209-10. PubMed ID: 14722376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.